What are the recommended eye drops for dry eye syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Eye Drops for Dry Eye Syndrome

For dry eye syndrome, preservative-free artificial tears containing methylcellulose or hyaluronate should be used as first-line therapy, applied at least twice daily and increased to hourly as needed based on symptom severity. 1, 2

First-Line Treatment Options

Artificial Tears

  • Formulation recommendations:
    • Preservative-free formulations are preferred, especially when more than 4 applications per day are needed 1
    • Key ingredients should include lubricants with polymeric base or viscosity agents:
      • Methylcellulose-based products
      • Hyaluronate-based products
    • Preservative-free artificial tears reduce iatrogenic effects of frequently applied medications 3

Application Schedule

  • Start with at least twice daily application
  • Increase frequency up to hourly as needed based on symptoms
  • For nighttime relief, use thicker ophthalmic ointments before bedtime 1
    • Note: Ointments cause blurred vision, so they're best used before sleep
    • Follow with morning lid hygiene to prevent blepharitis

Treatment Algorithm Based on Severity

Mild to Moderate Dry Eye

  1. Environmental modifications:

    • Humidify ambient air
    • Avoid air drafts
    • Practice conscious blinking
    • Lower computer screens below eye level 2
    • Identify and modify contributing medications (antihistamines, diuretics)
  2. Artificial tears:

    • Preserved formulations acceptable if used ≤4 times daily
    • Switch to preservative-free if more frequent application needed

Moderate to Severe Dry Eye

If inadequate response to artificial tears:

  1. Short-term topical therapy (2-4 weeks maximum):

    • Topical corticosteroids for acute inflammatory signs 1, 2
    • Monitor for increased intraocular pressure and infection risk
  2. Prescription medications:

    • Cyclosporine ophthalmic emulsion 0.05% (Restasis) 2, 4
      • Targets underlying inflammation
      • Note: May cause burning/stinging sensation
    • Lifitegrast 5% ophthalmic solution (Xiidra) 2
      • Faster onset compared to cyclosporine
      • Improves both signs and symptoms over 3-month period
  3. For refractory cases:

    • Autologous serum eye drops 1, 2
    • Consider referral to ophthalmologist with corneal disease expertise

Special Considerations

Contact Lens Wearers

  • Remove lenses prior to administering eye drops
  • May reinsert lenses 15 minutes after using Restasis 4
  • Patients with decreased tear production typically should avoid contact lenses 4

Sjögren's Syndrome

  • Consider serological workup if dry eye is severe or persistent 2
  • May benefit from systemic therapies:
    • Oral muscarinic agonists (pilocarpine, cevimeline) 2
    • Cevimeline may have fewer adverse effects than pilocarpine

Application Tips

  • Use immediately after opening single-use vials
  • Discard remaining contents after application
  • Do not allow vial tip to touch eye or any surface to prevent contamination 4
  • Fixed dosing (four times daily) may provide better symptomatic relief than as-needed use 5

Cautions

  • Avoid long-term use of preserved eye drops due to potential corneal toxicity
  • Monitor for adverse effects with topical corticosteroids or NSAIDs:
    • Corneal-scleral melts
    • Perforation
    • Ulceration
    • Severe keratopathy
    • Increased intraocular pressure
    • Cataract development 1

Regular follow-up with an eye care professional is essential to monitor response to treatment and adjust therapy as needed, particularly for moderate to severe cases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dry Eye Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A comparative study of two preservative-free tear substitutes in the management of severe dry eye.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.